Peter Starokadomskyy

Peter Starokadomskyy is a Senior Scientist at Kyverna Therapeutics, specializing in CAR-T Analytics Development since December 2022. Prior experience includes a tenure at UT Southwestern Medical Center from March 2010 to November 2022, where Peter led a group in molecular biology focused on rare diseases, contributing to the discovery of two new human autoinflammatory syndromes and authoring over three publications as a postdoctoral researcher in molecular immunology. Peter's educational background encompasses a Ph.D. in Biotechnology from the Institute of Molecular Biology and Genetics in Ukraine, along with postgraduate degrees in Immunology from the Weizmann Institute of Science and Research from UT Southwestern Medical Center. Notable earlier positions include postdoctoral research at the Weizmann Institute and as a Senior Biologist at Phage Biotechnology Corp, where Peter led successful pre-clinical trials and developed patented technologies.